Rhabdomyolysis After Intravenous Iron Sucrose Infusion During Pregnancy.

Clicks: 44
ID: 283557
2023
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #25 of 26 articles by views in Obstetrics and gynecology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Iron infusions have become increasingly common in the treatment of iron-deficiency anemia during pregnancy. Although iron infusions are generally well tolerated, adverse reactions have been reported. A pregnant patient was diagnosed with rhabdomyolysis after receiving a second dose of intravenous (IV) iron sucrose at 32 6/7 weeks of gestation. On admission to the hospital, creatine kinase was 2,437 units/L, sodium was 132 mEq/L, and potassium was 2.1 mEq/L. Intravenous fluids and electrolyte repletion were administered, with improvement of symptoms within 48 hours. Creatinine kinase normalized 1 week after hospital discharge. Rhabdomyolysis can be associated with IV iron infusion during pregnancy.
Reference Key
ge2023rhabdomyolysis Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Ge, Christina; Reyes, Jessica; Queenan, Ruth Anne; Gherman, Robert B
Journal Obstetrics and gynecology
Year 2023
DOI
10.1097/AOG.0000000000005157
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.